Acid-resistant Nissle 1917 engineering bacterium

Through genome editing, knocking out the lapC and gyrA genes, an acid-resistant Nissle 1917 engineering strain was constructed, which solved the problem of low survival rate in an acidic environment, improved survival rate and protein expression ability, and expanded its application field.

CN118979002APending Publication Date: 2024-11-19BEIJING INST OF TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410964634.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-18
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

E. coli Nissle 1917 has low survival rate in acidic environments, especially under the pH of human gastric juice, which affects its colonization efficiency and protein expression ability in the intestines, limiting its application potential in the fields of food and health products.

Method used

The lapC and gyrA genes of the strain were knocked out by genome editing technology to construct an acid-resistant Nissle 1917 engineering probiotic strain YCN74, which enhances its tolerance to the acidic environment and maintains a high level of heterologous protein expression.

Benefits of technology

It improves the survival rate and heterologous protein expression ability of the strain in an acidic environment, ensures that it remains active in a gastric acid environment, and has colonization advantages in the intestines, broadening its application potential in medical health and industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118979002A_ABST
    Figure CN118979002A_ABST
Patent Text Reader

Abstract

The invention provides an acid-resistant probiotic strain of Escherichia coli Nissle 1917, and belongs to the technical field of genetic engineering. The escherichia coli Nissle 1917 strain is modified by means of genetic engineering, the construction method and application of the engineering bacterium Nissle 1917 capable of growing under the acidic condition are provided, the engineering bacterium has good tolerance under the acidic condition, the heterologous protein expression level and the chemical production capacity are remarkably superior to those of a wild type, and the engineering bacterium has good application prospects. The invention is hopeful to provide a functional intestinal probiotic after oral administration of gastric acid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field:

[0001] The invention belongs to the technical field of genetic engineering, and specifically relates to the construction and application of an acid-resistant Nissle 1917 engineered probiotic. Background technology:

[0002] Escherichia coli Nissle 1917, as a widely recognized probiotic, can achieve long-term stable colonization in the human intestine. This strain is not only safe, but also can effectively regulate the balance of intestinal flora, enhance the immune prevention function of the intestinal mucosa, reduce inflammatory response, and has multiple functions of protecting the intestine, inhibiting the growth of pathogenic bacteria and regulating immune function. These characteristics make Nissle 1917 widely used in the fields of food and medicine. In addition, Nissle 1917 has a fast growth rate, which meets the chassis microbial characteristics required for industrial production and is suitable for industrial fermentation production. Despite this, there are relatively limited research reports on the metabolic engineering of Nissle 1917 to produce industrial products. In this study, a Nissle 1917 engineered probiotic strain with enhanced acid resistance was developed through genome editing technology, aiming to broaden its application potential in industrial production and medical health.

[0003] Although Escherichia coli Nissle 1917 is a widely recognized probiotic that has significant effects in regulating intestinal flora, enhancing immune prevention function, and reducing inflammatory responses, it is sensitive to changes in the acid-base environment. In particular, the survival rate of Nissle 1917 will drop significantly in an environment with a pH value below 4. Given that the pH value of human gastric juice is usually between 1 and 2, the orally ingested Nissle 1917 strain will suffer a large amount of inactivation when passing through the stomach, which not only reduces its protein expression ability but also affects its colonization efficiency in the intestine. In order to improve the survival rate of Nissle 1917 strains reaching the intestine through the oral route and expand its application potential in the field of food and health products, it is particularly urgent to develop Nissle 1917 engineered probiotic strains with enhanced acid resistance and high levels of heterologous protein expression. Therefore, the acid-resistant engineered probiotic strains obtained through genome editing technology can not only improve their survival rate in the gastric acid environment, but also maintain their probiotic functions, which is of great significance for promoting the widespread application of Nissle1917 strains in medical health and industrial production. Summary of the invention:

[0004] The present invention aims to provide a modified Escherichia coli Nissle 1917 engineered probiotic strain, which can grow under acidic conditions and has a significantly better heterologous protein expression level than the wild type. Through genome editing technology, the engineered strain exhibits good tolerance to acidic environments and maintains a high survival rate. The engineered strain of the present invention is not only expected to remain active after passing through the gastric acid environment under the oral route, but also has the potential to become a strain with colonization advantages in the intestine.

[0005] An acid-resistant Escherichia coli Nissle 1917 engineered probiotic of the present invention was deposited in the General Microbiology Center of China Microorganism Culture Collection Committee (CGMCC for short) on November 29, 2023, with the address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing. Its abbreviation is YCN74, the preservation number is CGMCC No. 29170, and the classification name is: Escherichia coli.

[0006] In a first aspect of the present invention, an engineered strain based on Nissle 1917 is provided, and compared with the wild-type strain, the altered genotype is: Nissle 1917-△lapC-gyrA. The detailed introduction of the genotype is as follows: wherein the original reference of the genome sequence of the Escherichia coli Nissle 1917 is: RefSeq: NZ_CP022686; the endogenous plasmid of the Escherichia coli Nissle 1917 is removed; the genome of the Escherichia coli Nissle 1917 is finally transformed into: YCN74 after the sequence between the two genes lapC and gyrA is knocked out.

[0007] In a second aspect of the present invention, under Luria-Bertani (LB) medium culture conditions, lapC and gyrA on the genome of Escherichia coli MG1655 are essential genes that are knocked out, and the strain will not be able to grow in LB medium. Homologous sequences of lapC and gyrA also exist in the genome of Escherichia coli Nissle1917, and the similarities with the lapC and gyrA nucleic acid sequences of Escherichia coli MG1655 are 98.35% and 97.91%, respectively. We set the 58458 base pair nucleic acid sequence between the two homologous sequences on the genome of Escherichia coli Nissle 1917 as a non-essential gene fragment under LB culture conditions, which can be knocked out from the genome, thereby reducing the expression of non-essential genes for survival, alleviating the metabolic burden, and possibly producing a new phenotype.

[0008] In a third aspect of the present invention, the present invention provides a method for constructing the above-mentioned engineered probiotics, the method comprising: comparing the sequences of lapC and gyrA on the genome of Escherichia coli MG1655 and the two homologous genes on the genome of Escherichia coli Nissle 1917, and knocking out the segment between the two homologous genes lapC and gyrA using the CRISPR-Cas9 gene editing method. The segment between lapC and gyrA is further knocked out in segments to further obtain a more streamlined acid-resistant strain YCN74-1.

[0009] In the fourth aspect of the present invention, the present invention uses the constructed engineered bacteria to test the expression level of heterologous proteins, and tests the changes in the expression intensity of green fluorescent protein of the YCN74 strain and the acid-resistant YCN74-1 strain in a pH 4 culture medium.

[0010] In the fifth aspect of the present invention, the present invention uses the constructed engineered bacteria to carry out shake flask production tests of lycopene chemicals, and uses plasmids to overexpress lycopene production pathway genes to test the lycopene production of the Nissle 1917+p-lycopenen strain and the acid-resistant YCN74+p-lycopenen strain.

[0011] In the sixth aspect of the present invention, the present invention uses the constructed engineered bacteria to carry out a survival rate test under the condition of artificial gastric juice at pH 3, and uses the prepared simulated artificial gastric juice at pH 3 to test the survival rate of the YCN74 strain under the condition of artificial gastric juice at pH 3.

[0012] Other features of the present invention will be described in detail in the specific implementation section. Description of the drawings:

[0013] Figure 1 This is the growth curve of the strain before and after the transformation under normal LB conditions in the present invention;

[0014] Figure 2 This is the growth curve of YCN74 in the present invention under LB conditions of pH 4;

[0015] Figure 3 To provide the green fluorescent protein expression intensity of the strain before and after testing the transformation in the present invention;

[0016] Figure 4 The present invention provides a method for testing the lycopene production capacity of the strain before and after transformation;

[0017] Figure 5 The sequencing results of the region between lapC and gyrA before and after knockout;

[0018] Figure 6Peak diagram of sequencing results before and after knockout of the segment between lapC and gyrA;

[0019] Figure 7 This is the growth curve of YCN74-1 in the present invention under LB conditions of pH 4;

[0020] Figure 8 The sequencing results of the 10458bp gene sequence between the lapC and gyrA genes near the gyrA end before and after knockout;

[0021] Fig. 9 The peak diagram of sequencing results of the 10458bp gene sequence between the lapC and gyrA genes near the gyrA end before and after knockout;

[0022] Fig.10 The present invention provides a method for testing the gastric acid tolerance survival rate of the YCN74 strain under artificial gastric fluid conditions at pH 3. Specific implementation method:

[0023] The present invention is described below by specific embodiments. Unless otherwise specified, the technical means used in the present invention are methods known to those skilled in the art. In addition, the embodiments should be understood as illustrative rather than limiting the scope of the present invention, and the essence and scope of the present invention are limited only by the claims. For those skilled in the art, various changes or modifications to the material composition and dosage in these embodiments, without departing from the essence and scope of the present invention, also belong to the protection scope of the present invention.

[0024] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0025] The present invention will be further explained below through specific examples.

[0026] Example 1 Construction of Escherichia coli YCN74 strain and YCN74-1 strain with simplified genome

[0027] The nucleic acid sequence of 58458 base pairs (bp) between the two homologous genes lapC and gyrA on the genome of Escherichia coli Nissle 1917 (serotype O6:K5:H1, NCBI sequence number: NZ_CP022686.1) was defined as a non-essential fragment under LB culture conditions. Including CIW80_04795, CIW80_04800, CIW80_04805, CIW80_04810, CIW80_04815, CIW80_04820, CIW80_04825, CIW80_04830, CIW80_04835, CIW80_04840, CIW80_04845, CIW80_04850, CIW80_04855, CIW80_04860, CIW80_048 65. CIW80_04870, CIW80_04875, CIW80_04880, CIW80_04885, CIW80_04890, CIW80_04895, CIW80_04900, CI W80_04905, CIW80_04910, CIW80_04915, CIW80_04920, CIW80_04925, ccmD, CIW80_04935, ccmB, CIW80_0494 5. CIW80_04950, napB, CIW80_04960, CIW80_04965, CIW80_04970, CIW80_04975, napF, CIW80_04985, CIW80 _04990, mqo, CIW80_05000, CIW80_05005, CIW80_05010, CIW80_05015, CIW80_05020, CIW80_05025, CIW80_0 5030, CIW80_05035, CIW80_05040, CIW80_05045, CIW80_05050, CIW80_05055, CIW80_05060, CIW80_05065, CIW80_05070, CIW80_05075, CIW80_05080, CIW80_05085, CIW80_05090, CIW80_05095, CIW80_05100, a total of 62 genes.

[0028] Using wild-type Nissle 1917 as the base strain, competent cells were prepared, homologous arms and sgRNA for homologous recombination were designed, and the determined gene fragments were knocked out from the genome by CRISPR-Cas9 gene editing. Because a single N20 can cause a double-strand break in the genome, but for a long editing region, the break region is too far away from the homologous recombination regions at both ends, and homologous recombination cannot be effectively initiated for double exchange. Therefore, the editing efficiency of ultra-long fragments using a single N20 system is low, and it is difficult to obtain a knockout strain. We used a double N20 method to knock out long fragments in the strain.

[0029] More specifically, taking YCN74 as an example, the construction method includes:

[0030] (1) Using the Nissle 1917 genome as a template, LF / LR as primers, PCR amplification was performed to obtain the upstream homology arm L-arm, and RF / RR as primers to obtain the downstream homology arm R-arm. The total PCR reaction system was 50 μL, including 25 μL Primestar high-fidelity enzyme, 20 μL ddH2O, 2 μL LF (RF), 2 μL LR (RR) and 1 μL Nissle 1917 genome as a template. The PCR program was: 98°C for 1 min, 56°C for 15 s, 72°C for 80 s, and 30 cycles were set. The target size was about 0.6 kb.

[0031] (2) Use the fusion PCR method to obtain the L-arm+R-arm fragment, making it a fragment of about 1.2 kb, which is the repair fragment.

[0032] (3) Design two upstream and downstream sgRNA sequences according to the deletion sequence, use pTargetF as a template, sgRNA-F1 / sgRNA-R1 as primers, and sgRNA-F2 / sgRNA-R2 as primers to introduce two sgRNAs into the plasmid backbone. Connect the backbone and L-arm and R-arm by the Gibson assembly method to obtain plasmid pTargetF-1, and then transform the ligation product into 100 μL of commercial Escherichia coli JM109 competent cells, ice bath for 20 minutes, heat shock at 42°C for 45 seconds, immediately place on ice for 2 minutes, and then immediately add 700 μL of SOC medium, and resuscitate in a shaker at 37°C and 200 rpm for 45 minutes. After centrifugation at 5000 rpm for 2 minutes, remove 500 μL of supernatant, evenly spread the remaining bacterial solution on the corresponding resistance plate, place it at 37°C overnight for culture, pick a single clone, and extract the plasmid for sequencing verification. If the corresponding N20 and homology arms in the sequencing results are successfully introduced, it means that the correct knockout plasmid is obtained.

[0033] (4) Electroporation: The pCas9 plasmid was transferred into the Nissle 1917 competent cell and revived in a shaking incubator at 37°C and 200 rpm for 2 h. 200 μL of the culture was spread on an LB plate containing 20 μg / mL kanamycin resistance and cultured at 30°C overnight.

[0034] (5) Prepare competent cells of Nissle 1917+pCas9 strain.

[0035] (6) Add pTargetF-1 to competent cells for electroporation and select transformants with kanamycin / ampicillin.

[0036] (7) The Nissle 1917+pCas9+pTargetF-1 transformants were inoculated into liquid culture medium, IPTG and arabinose were added to induce editing, and the transformants were screened by plating.

[0037] (8) The transformants were verified using external primers F1 / R2 and internal primers F3 / R4. Primers F1 / R2 produced a band in PCR amplification, but primers F3 / R4 did not produce a band, indicating that the Nissle1917 strain with the 937,412-995,869 (58.5 kb) fragment deleted was obtained. The sequencing results are shown in Figure 5 As shown, the peak diagram of sequencing results is as follows Figure 6 shown.

[0038] (9) Subsequently, the pTargretF-1 plasmid, whose replicon is thermosensitive, was eliminated by inducing the elimination of the plasmid by culturing at 37°C, and the pCas9 plasmid was eliminated by culturing on sucrose plates to obtain the YCN74 strain, which was then stored in a −80°C refrigerator.

[0039] The specific primer sequences are shown in the table below:

[0040]

[0041]

[0042] The segment between lapC and gyrA on the genome of Nissle 1917 was knocked out in sections, and the 10458 bp gene sequence near the gyrA end of the segment between lapC and gyrA in the genome of Nissle 1917 was deleted to obtain a more streamlined strain YCN74-1. The sequencing results are as follows Figure 8 As shown, the peak diagram of sequencing results is as follows Fig. 9 shown.

[0043] Example 2: Knockout of gene fragment had no effect on the growth of YCN74 strain

[0044] This example is used to illustrate that knocking out the 58.5 kb long fragment between lapC and gyrA in the genome has no significant effect on the growth of the YCN74 strain in the nutrient-rich LB medium.

[0045] LB medium composition: 10 g / L peptone, 5 g / L yeast extract, 10 g / L NaCl.

[0046] Although the knockout of non-essential genes usually has no significant effect on the growth and metabolism of the strain, there are many such genes in the genome. By strategically knocking out these non-essential gene modules, more biological energy can be effectively redistributed to functional modules and essential genes, thereby improving metabolic efficiency. This approach helps to avoid unnecessary loss of energy and carbon sources during metabolic engineering, optimize the performance of the strain, and make it more suitable for industrial applications and bioproduction processes. Therefore, we knocked out the gene segment between lapC and gyrA and evaluated the performance of the knockout strain.

[0047] The wild-type Nissle 1917 strain and the constructed YCN74 strain were streaked on LB plates and cultured at 37°C for 12 hours. Three single colonies were picked from the plates and inoculated into shaking tubes, and cultured at 37°C and 220rpm for about 12 hours. Then, it was transferred to 5mL LB medium at a 1% inoculum, and continued to be cultured at 37°C and 220rpm for 24 hours. The first 6 samples were taken every 2 hours, and the last sample was taken 12 hours later and stored at 4°C. A total of 7 samples were taken. After sampling, the OD600nm absorbance was measured together. Take 200μL each time to a 96 ELISA plate, and use an ELISA reader to measure OD600nm. If the OD value is greater than 0.8, the bacterial solution needs to be diluted appropriately so that the OD600nm measured by the ELISA reader is between 0.2-0.8. At the same time, blank LB was used as a control, and the actual OD value was subtracted from the blank control to obtain the true OD value, and the growth curves of the wild-type Nissle 1917 strain and the YCN74 strain were drawn.

[0048] The results are as follows Figure 1 As shown, compared with the wild-type Nissle 1917 strain, the YCN74 strain can grow normally, and the OD600nm can reach about 1.8 in 24 hours. This shows that there are no genes related to the normal growth of Nissle 1917 in the knocked-out region, and the strain can be used in the field of metabolic engineering.

[0049] Example 3 YCN74 strain has growth advantage in acidic environment

[0050] The composition of LB medium at pH 4: 10 g / L peptone, 5 g / L yeast extract, 10 g / L NaCl, titrated to pH = 4 using concentrated hydrochloric acid.

[0051] During the fermentation production process, the growth environment of the strain changes over time. The accumulation of organic acids in the culture medium causes the pH value to gradually decrease, which puts pressure on the survival of the cells, inhibits the metabolic process, and ultimately leads to a decrease in the yield of the target product. Therefore, the development of strains that can tolerate low pH environments is crucial for industrial production. This study plans to screen out strains with low pH tolerance through large-fragment gene knockout technology, and conduct a detailed analysis of their genotypes in order to obtain strains with higher stability and productivity under industrial fermentation conditions. This example will verify the tolerance of wild-type Nissle1917 strains and YCN74 strains in acidic environments.

[0052] Determine the growth rate of YCN74 strain in LB at pH 4. Pick a single colony in 5 mL LB medium, culture at 37°C for 14 h, inoculate 5 mL LB medium at pH 4 at a ratio of 1:100, and culture 3 times for each bacterium at 37°C. Take samples at 2h, 4h, 8h, 10h, 12h, and 26h, and store at 4°C. Take samples 6 times in total, and measure the OD600nm absorbance after sampling.

[0053] The results are as follows Figure 2 As shown in the figure, compared with the normal LB culture condition (pH7.0), the Nissle 1917 strain did not grow at all under the condition of pH4, indicating that the over-acid condition brought great growth pressure to the Nissle 1917 strain. Under the condition of pH4, the Nissle 1917 strain still did not grow in the first 12 hours, but after 12 hours, the wild-type Nissle 1917 strain and the YCN74 strain began to grow. By 26 hours, the OD600nm of the wild-type Nissle 1917 strain was measured to be about 0.6, while the OD600nm of the YCN74 strain was measured to be about 1.4. This shows that under the condition of pH4, the Nissle 1917 strain was brought with obvious growth pressure, but it would not be lethal. As time went on and after further adaptation to the environment, the Nissle 1917 strain showed slow growth. The YCN74 strain could grow rapidly in the later stage, thereby screening and obtaining a large-fragment knockout strain that could tolerate pH4.

[0054] Example 4: YCN74 strain has stronger heterologous protein expression ability under acidic conditions

[0055] The composition of LB medium at pH 4: 10 g / L peptone, 5 g / L yeast extract, 10 g / L NaCl, titrated to pH = 4 using concentrated hydrochloric acid.

[0056] The expression of fluorescent protein can be used as an indicator of the survival and functional status of the strain under acidic conditions, helping to evaluate the tolerance of the knockout strain to low pH environments. By observing the expression intensity of the fluorescent protein, it is possible to visually verify whether the gene knockout is successful and whether the knocked-out gene is activated under the expected conditions. For industrial microorganisms that need to work under acidic conditions, such as the production of organic acids and biofuels, this test helps to develop industrial strains with higher productivity and stability, and also provides important experimental data and methods for the improvement and application of industrial microorganisms.

[0057] Determine the fluorescence expression intensity of the YCN74 strain in LB at pH 4. Pick a single colony in 5 mL LB medium, culture at 37 ° C for 14 h, inoculate 5 mL LB medium at pH 4 at a ratio of 1:100, and culture 3 times for each bacterium at 37 ° C. Take samples at 2h, 4h, 8h, 10h, 12h, and 26h, and store them at 4 ° C. Take samples 6 times in total. After sampling, measure the absorbance value of sfGFP at an excitation wavelength of 485nm and an emission wavelength of 510nm.

[0058] The results are as follows Figure 3 As shown in the figure, under pH 4 conditions, the Nissle 1917 strain and the YCN74 strain had almost no growth in the first 12 hours, but after 12 hours, the YCN74 strain began to grow, and at 26 hours, the OD510nm of the wild-type Nissle 1917 strain reached about 2000, while the OD510nm of the wild-type Nissle 1917 strain reached about 600. This shows that under pH 4 conditions, the YCN74 strain can grow rapidly in the later stage, and the YCN74 large fragment knockout strain that can tolerate pH 4 has good heterologous protein expression ability.

[0059] Example 5 Lycopene production capacity test of YCN74+p-lycopenen

[0060] The composition of LB medium at pH 4: 10 g / L peptone, 5 g / L yeast extract, 10 g / L NaCl, titrated to pH = 4 using concentrated hydrochloric acid.

[0061] Determine the lycopene production capacity of the YCN74+p-lycopenen strain in acidic LB medium. Pick a single colony in 5mL LB medium, culture overnight at 37℃ for 12h, inoculate 5mL pH4 LB medium at a ratio of 1:100, and culture 3 times for each bacterium at 37℃ for 24h. Centrifuge and dry 2mL of the bacteria to weigh the dry weight of the cells, and at the same time, centrifuge 2mL of the bacterial solution at 6000g for 2min, extract with 200μL acetone, place in a metal bath at 55℃ for 30min, centrifuge the bacteria, and use an ELISA reader to measure the OD474nm value of the supernatant, and finally calculate the lycopene content per mg of dry cell weight.

[0062] The results are as follows Figure 4 As shown, under the condition of pH 4, after culturing for 24 hours, YCN74 grew normally, and the final lycopene production reached 0.22 mg of lycopene per mg of cell dry weight. This indicates that the YCN74 large fragment knockout strain that can tolerate pH 4 has good potential for chemical production.

[0063] Example 6 Growth of YCN74-1 strain in LB medium at pH 4

[0064] In order to further determine the key gene clusters that are tolerant under acidic conditions in lapC and gyrA, the non-essential fragments of 58.5 kb were knocked out in segments to obtain a more streamlined acid-resistant YCN74-1 strain. Under the acidic conditions of LB at pH 4, the more streamlined strain can remove more non-essential genes, which helps to simplify the genetic background of the strain and facilitate genetic manipulation and expression analysis of functional genes. The growth determination process is the same as in Example 3.

[0065] The results are as follows Figure 7 As shown in the figure, under pH 4 conditions, the wild-type Nissle 1917 strain still did not grow in the first 12 hours, but after 12 hours of cultivation, the YCN74 strain and the YCN74-1 strain began to grow, and after 26 hours of cultivation, the OD600nm of the YCN74 strain and the YCN74-1 strain reached about 1.5. This shows that under pH 4 conditions, the YCN74-1 strain can grow rapidly in the later stage, thereby obtaining a large fragment knockout strain that can tolerate pH 4.

[0066] Example 7 The YCN74 strain with some non-essential genes knocked out has a good survival rate under the artificial gastric fluid condition of pH 3

[0067] In the actual human environment, it is difficult for exogenous bacteria to pass through the gastric environment and reach the intestine. Conducting tolerance experiments in artificial gastric juice in vitro is crucial to understanding the ability of strains to survive in the human body and the possibility of exerting the expected efficacy. Through these tests, strains with good gastric acid tolerance can be screened, which is of great significance for the development of new probiotic products or industrial fermentation processes.

[0068] Preparation of artificial gastric juice: Use sterile 0.85% physiological saline, 3g / L pepsin, titrate with concentrated hydrochloric acid to pH=3, and filter with a 0.22μm filter membrane before use.

[0069] Determine the tolerance of the YCN74 strain to artificial gastric juice at pH 3. Centrifuge the cultured bacterial solution at 6000g for 2 minutes, discard the supernatant, add an equal volume of physiological saline, wash the bacteria once, discard the supernatant after centrifugation, add an equal volume of artificial gastric juice, and oscillate to mix to form the original bacterial solution. Dilute the original bacterial solution and count it with a spreader, and repeat three times as the colony count at 0h. At the same time, put the original bacterial solution mixed with gastric juice into a 37℃ incubator and react for 3h. Take the original bacterial solution containing gastric juice after the reaction for 3h and dilute and count it with three times as the colony count at 3h. The survival rate of the colony is equal to the average colony count at 3h divided by the average colony count at 0h multiplied by 100%.

[0070] The results are as follows Fig.10 As shown, the survival rate of the colony of strain YCN74 after 3 hours of artificial gastric acid treatment reached 59.03%, and the survival rate of the control group reached 21.36%, which was increased by 276% compared with the survival rate of the control group.

[0071] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the patent. It should be pointed out that, for ordinary technicians in this field, the above-mentioned implementation methods can also be modified, combined and improved without departing from the concept of this patent, which all belong to the protection scope of this patent. Therefore, the protection scope of this patent shall be based on the claims.

Claims

1. A derivative strain of Escherichia coli Nissle 1917, with the deposit number of China National Center for Microbiological Culture Collection being 29170, characterized in that: Compared with the reference genome NZ_CP022686.1 of Nissle 1917, its genome has gene deletions and has acquired a phenotype that can tolerate acidic conditions.

2. The acid-resistant strain of Escherichia coli Nissle 1917 according to claim 1, characterized in that In an acidic environment with a pH greater than or equal to 4, the growth rate was significantly increased compared to the wild-type strain.

3. The acid-resistant strain of Escherichia coli Nissle 1917 according to claim 1, characterized in that: After being treated under acidic conditions with a pH value greater than or equal to 3, the cell line can show a higher survival rate than the wild type.

4. The genome editing of Escherichia coli Nissle 1917 according to claim 1 includes but is not limited to: a derivative of the Nissle 1917 strain, in which the gene segment between the lapC and gyrA genes in the genome is deleted.

5. An acid-resistant chassis strain of Escherichia coli Nissle 1917 according to claim 1, including but not limited to expressing fluorescent protein sfGFP, producing lycopene, producing organic acids, etc. under acidic conditions, as a chassis strain for industrial production and treatment of gastrointestinal diseases.